NICE has recommended cemiplimab for eligible adults with recurrent or [...]
The National Institute for Health and Care Excellence has recommended [...]
The National Institute for Health and Care Excellence (NICE) has [...]
People with extensive-stage small cell lung cancer in England and [...]
The National Institute for Health and Care Excellence has [...]
The National Institute for Health and Care Excellence (NICE) has [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
